openPR Logo
Press release

Global Adrenal Cancer Diagnostics Market 2024 Opportunity Assessment, Size, Growth Rate And Forecast To 2033

04-19-2024 11:36 AM CET | Health & Medicine

Press release from: The Business Research Company

Adrenal Cancer Diagnostics Market

Adrenal Cancer Diagnostics Market

The adrenal cancer diagnostics market size has grown strongly in recent years. It will grow from $130.84 billion in 2023 to $140.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased incidence and awareness, genetic and molecular testing advances, biopsy techniques improvement, enhanced endocrine testing, integration of artificial intelligence (ai).

The adrenal cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $180.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to personalized medicine approaches, rise in minimally invasive procedures, telemedicine and remote consultations, liquid biopsy development, expanded genetic counseling services. Major trends in the forecast period include regulatory support for diagnostic innovations, digital pathology adoption, advancements in imaging technologies, liquid biopsy development, genomic profiling for precision medicine.

Market Overview -
Adrenal cancer diagnostics refers to the process of identifying and diagnosing adrenal cancer, which is cancer that originates in the adrenal glands located above the kidneys. This process involves a series of medical evaluations, tests, and procedures designed to determine whether a person has adrenal cancer. It is essential for effective treatment planning and management.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp

Rising Cigarette Smoking Boost The Adrenal Cancer
The rising cigarette smoking is expected to propel the growth of the adrenal cancer diagnostics market going forward. Cigarette smoking refers to the act of inhaling and exhaling the fumes of burning tobacco, which contains nicotine, an addictive alkaloid that can have both stimulating and tranquilizing psychoactive effects. Cigarette smoking has been associated with an increased risk of adrenal cancer, including adrenal adenomas and adrenocortical carcinomas. The carcinogens in tobacco smoke can damage the DNA in adrenal cells, leading to mutations that can cause cancer. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Additionally, the total number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the rising cigarette smoking is driving the growth of the adrenal cancer diagnostics market.

Competitive Landscape -
Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK plc, AstraZeneca plc, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

Increasing Focus On Advanced Diagnostic Technological Products To Drive The Revenues
Major companies operating in the adrenal cancer diagnostics market are developing innovative products with advanced technologies such as the High-V MRI platform and DryCool technology to increase their profitability in the market. The high-V MRI platform combines the power of digitalization with a new field strength of 0.55T, resulting in excellent diagnostic quality for routine and new clinical applications, whereas DryCool technology is a virtually helium-free scanner that uses a closed-loop cooling system to cool the magnet. For instance, in November 2021, Siemens Healthcare GmbH, a Germany-based healthcare company, introduced a new MRI scanner called Magnetom Free.Star1 for adrenal cancer diagnostics. The scanner is designed to be cost-effective and easy to operate, and it is based on Siemens Healthineers' revolutionary High-V MRI platform and DryCool technology. It is expected to improve patient outcomes by enabling earlier and more accurate diagnosis of a wide range of medical conditions.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report

Key Segments -
The adrenal cancer diagnostics market covered in this report is segmented -
1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy
2) By Treatment: Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, Other Treatments
3) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types
4) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Adrenal Cancer Diagnostics Market 2024 Opportunity Assessment, Size, Growth Rate And Forecast To 2033 here

News-ID: 3470008 • Views:

More Releases from The Business Research Company

Shelf Image Recognition Artificial Intelligence Market Poised for Robust Growth, …
How Much Is the Shelf Image Recognition Artificial Intelligence Market Expected to Expand by 2025? The artificial intelligence market focused on recognizing items on shelves has experienced a remarkable surge lately; this segment is projected to expand from generating $1.43 billion in 2024 to reaching $1.82 billion in 2025, reflecting an impressive compound annual growth rate of 26.8%. This substantial expansion observed during the past period stems from several key factors,
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Leading Companies
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector. Projected Growth and Market Size of the Nano Antibodies Market The nano antibodies market is anticipated
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody Market Landscape
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward. Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Leading Companies
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector. Projected Growth and Market Size of the Nano Antibodies Market The nano antibodies market is anticipated

All 5 Releases


More Releases for Adrenal

Adrenal Insufficiency Market to Reach USD 4.03 Billion by 2034
Pune, India - December 2025 - The global Adrenal Insufficiency Market, valued at USD 2.38 billion in 2024, is projected to reach USD 4.03 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of autoimmune disorders, enhanced diagnostic awareness, and advancements in glucocorticoid replacement therapies are fueling consistent market growth. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72005 Market Summary The Adrenal Insufficiency Market is
Adrenal crisis Market Insights Highlight Expanding Outlook Till 2034, DelveInsig …
DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Rising Cigarette Smoking Boost The Adrenal Cancer: Key Factor Driving The Growth …
The Adrenal Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Adrenal Cancer Diagnostics Market Size During the Forecast Period? Over the past few years, the market size for adrenal cancer diagnostics has been experiencing strong growth. It is projected to
Congenital Adrenal Hyperplasia Treatment Market Report and Forecast 2024-2032
The congenital adrenal hyperplasia treatment market size was valued at USD 422.9 million in 2023, driven by increasing government funding and assistance along with joint research. The market size is anticipated to grow at a CAGR of 8.10% during the forecast period of 2024-2032 to achieve a value of USD 852.42 million by 2032. Congenital Adrenal Hyperplasia Treatment: Introduction Congenital Adrenal Hyperplasia (CAH) treatment typically involves lifelong replacement of deficient hormones. For
Addison's Disease Testing: Diagnostic Approaches for Unveiling Adrenal Insuffici …
Addison Disease Testing Market 2023 Forecast: Unveiling Opportunities and Growth Addison Disease Testing Market research report helps to recognize the market challenges and opportunities. Global Addison Disease Testing Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including
Adrenal Insufficiency Market to Witness Growth by 2032, estimates DelveInsight
DelveInsight's "Adrenal Insufficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adrenal Insufficiency, historical and forecasted epidemiology as well as the Adrenal Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Adrenal Insufficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Adrenal Insufficiency market size